QC
CELG

QCM Cayman’s Celgene Corp CELG Stock Holding History

QCM Cayman’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-4,691
Closed -$373K – 195
2018
Q2 		$373K Buy
+4,691
New +$389K 1.73% 18
2016
Q3 		– Sell
-15,134
Closed -$1.64M – 412
2016
Q2 		$1.49M Buy
+15,134
New +$1.57M 0.65% 25
2015
Q4 		– Sell
-2,005
Closed -$217K – 307
2015
Q3 		$217K Buy
+2,005
New +$249K 0.07% 162
2014
Q2 		– Sell
-3,872
Closed -$294K – 400
2014
Q1 		$270K Buy
+3,872
New +$307K 0.06% 196

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QCM Cayman's CELG Position: Q3 2018 in Review

QCM Cayman sold out of Celgene Corp (CELG) in Q3 2018, closing a stake of 4,691 shares — an estimated $373K sold.

QCM Cayman first reported a position in CELG in Q1 2014 and held it in 4 quarters. The position peaked at $1.49M in Q2 2016. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

  • QCM Cayman reported no remaining Celgene Corp position as of Q3 2018 after selling out during the quarter.
  • QCM Cayman sold 4,691 Celgene Corp shares in Q3 2018, an estimated $373K.
  • QCM Cayman first reported a position in Celgene Corp in Q1 2014 and held it in 4 quarters.
  • QCM Cayman's Celgene Corp position peaked at $1.49M in Q2 2016.
  • 1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on QCM Cayman's 13F filing for Q3 2018, filed 14 Nov 2018.